As of 2024-09-10, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 11.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.48 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -79.9%.
The range of the Relative Valuation is 8.41 - 19.35 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.6x - 6.7x | 6.6x |
| Forward P/E multiples | 9.4x - 17.3x | 13.4x |
| Fair Price | 8.41 - 19.35 | 11.74 |
| Upside | -85.6% - -66.9% | -79.9% |
| Date | P/E |
| 2024-09-09 | 45.59 |
| 2024-09-06 | 47.17 |
| 2024-09-05 | 47.37 |
| 2024-09-04 | 49.07 |
| 2024-09-03 | 49.14 |
| 2024-08-30 | 49.70 |
| 2024-08-29 | 48.69 |
| 2024-08-28 | 48.90 |
| 2024-08-27 | 49.31 |
| 2024-08-26 | 49.34 |
| 2024-08-23 | 48.09 |
| 2024-08-22 | 47.18 |
| 2024-08-21 | 47.83 |
| 2024-08-20 | 47.70 |
| 2024-08-19 | 47.74 |
| 2024-08-16 | 46.79 |
| 2024-08-15 | 47.63 |
| 2024-08-14 | 46.15 |
| 2024-08-13 | 45.96 |
| 2024-08-12 | 46.53 |
| 2024-08-09 | 45.14 |
| 2024-08-08 | 43.99 |
| 2024-08-07 | 44.45 |
| 2024-08-06 | 49.34 |
| 2024-08-05 | 46.12 |
| 2024-08-02 | 47.56 |
| 2024-08-01 | 49.78 |
| 2024-07-31 | 51.24 |
| 2024-07-30 | 50.19 |
| 2024-07-29 | 49.53 |
| 2024-07-26 | 49.31 |
| 2024-07-25 | 48.36 |
| 2024-07-24 | 49.32 |
| 2024-07-23 | 50.46 |
| 2024-07-22 | 48.39 |
| 2024-07-19 | 48.48 |
| 2024-07-18 | 47.83 |
| 2024-07-17 | 49.10 |
| 2024-07-16 | 50.07 |
| 2024-07-15 | 49.29 |
| 2024-07-12 | 49.51 |
| 2024-07-11 | 50.09 |
| 2024-07-10 | 48.63 |
| 2024-07-09 | 47.82 |
| 2024-07-08 | 48.62 |
| 2024-07-05 | 47.90 |
| 2024-07-03 | 47.42 |
| 2024-07-02 | 48.83 |
| 2024-07-01 | 49.46 |
| 2024-06-28 | 49.65 |